Thank you for the question.
In terms of supplies of western medicine being available—antivirals, for example—we feel there are sufficient supplies available, and these have in fact been pre-positioned in the communities that need them. Estimates have been made to determine the amounts that should be pre-positioned given what we know about H1N1 right now.
That's not to say one would not want to take into account utilization of traditional medicine. I would suggest that the traditional medicine first nations may wish to use may be quite different from that available in China. We'd want to ensure there were practitioners, presumably in China, who would know the particular circumstances in which to use Chinese traditional medicine. So I think we would be very open to assist if communities wished to use those. I think we would want to make sure there wasn't an interaction between traditional medicines...because there have been instances in the past of western medicine in fact interfering with traditional medicine, or the other way around.
The challenge is actually to do clinical trials for those kinds of medicines. In fact one needs large numbers of people in a very controlled clinical trial, and that's not something one can do in the short term considering the number of cases of H1N1 we have. Maybe China has large numbers of cases on which it could actually do research, but in the short term, we're promoting and trying to combine as much as possible the utilization of traditional medicine—if in fact there are practitioners available in the community. People have to be fully informed as to what is available.